HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Catherine Sautès-Fridman Selected Research
Catherine Sautès-Fridman Research Topics
Disease
84
Neoplasms (Cancer)
01/2024 - 03/2002
10
Tertiary Lymphoid Structures
10/2023 - 03/2011
10
Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 03/2015
8
Inflammation (Inflammations)
01/2022 - 04/2010
6
Melanoma (Melanoma, Malignant)
01/2023 - 11/2002
6
B-Cell Lymphoma (Lymphoma, B Cell)
05/2013 - 07/2007
5
Lung Neoplasms (Lung Cancer)
01/2021 - 04/2010
4
Carcinogenesis
01/2024 - 11/2012
4
Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 01/2011
3
Neoplasm Metastasis (Metastasis)
01/2020 - 11/2002
3
Lymphoma (Lymphomas)
01/2016 - 01/2012
2
Sarcoma (Soft Tissue Sarcoma)
01/2024 - 01/2020
2
Thrombotic Microangiopathies
01/2022 - 10/2012
2
Prostatic Neoplasms (Prostate Cancer)
01/2019 - 10/2012
2
Disease Progression
01/2019 - 08/2017
2
Carcinoma (Carcinomatosis)
01/2019 - 09/2012
2
Obesity
07/2015 - 04/2015
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2014 - 08/2012
2
Intraocular Lymphoma
01/2013 - 07/2007
2
Tuberculosis (Tuberculoses)
09/2012 - 08/2012
2
Infections
02/2011 - 05/2007
1
Heart Failure
01/2022
1
Hypertension (High Blood Pressure)
01/2022
1
Liver Failure
01/2022
1
Digestive System Diseases
01/2022
1
Massive Hepatic Necrosis
01/2022
1
Kidney Neoplasms (Kidney Cancer)
01/2021
1
Alzheimer Disease (Alzheimer's Disease)
10/2020
1
Microsatellite Instability
01/2020
Drug/Important Bio-Agent (IBA)
12
Antigens
IBA
01/2023 - 10/2012
12
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2014
9
Immune Checkpoint Inhibitors
IBA
01/2024 - 01/2019
9
Antibodies
IBA
10/2023 - 12/2006
9
Cytokines
IBA
01/2023 - 03/2002
8
Immunoglobulin G (IgG)
IBA
10/2023 - 11/2002
8
Vaccines
IBA
05/2015 - 08/2012
7
Monoclonal Antibodies
IBA
01/2024 - 01/2010
7
Complement System Proteins (Complement)
IBA
01/2022 - 05/2007
6
DNA (Deoxyribonucleic Acid)
IBA
12/2019 - 12/2012
6
Antineoplastic Agents (Antineoplastics)
IBA
04/2015 - 12/2012
6
Toll-Like Receptor Agonists
IBA
01/2014 - 08/2012
5
Ipilimumab
IBA
01/2023 - 10/2019
5
Proteins (Proteins, Gene)
FDA Link
01/2021 - 08/2008
5
Ligands
IBA
01/2019 - 04/2010
4
Chemokines
IBA
08/2016 - 01/2011
4
Imiquimod (Aldara)
FDA Link
Generic
01/2014 - 08/2012
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2024 - 03/2012
3
Sunitinib (Sutent)
FDA Link
01/2022 - 03/2015
3
Nivolumab
IBA
01/2022 - 10/2019
3
Antigen-Antibody Complex (Immune Complex)
IBA
01/2021 - 11/2002
3
Protein Subunit Vaccines
IBA
04/2015 - 12/2012
3
Toll-Like Receptors (Toll-Like Receptor)
IBA
04/2013 - 01/2011
3
IgG Receptors (Fc gamma RI)
IBA
01/2010 - 11/2002
3
Neoplasm Antibodies
IBA
12/2008 - 11/2002
2
Autoantibodies
IBA
01/2024 - 10/2012
2
Autoantigens
IBA
01/2024 - 01/2023
2
Immunoglobulin A (IgA)
IBA
10/2023 - 01/2022
2
guadecitabine
IBA
01/2023 - 12/2019
2
Tyrosine Kinase Inhibitors
IBA
01/2022 - 03/2015
2
Complement C1q (C1q Complement)
IBA
01/2022 - 01/2019
2
Paraffin
IBA
01/2021 - 01/2006
2
Complement Factor H (Factor H)
IBA
01/2021 - 10/2012
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
08/2017 - 05/2012
2
Messenger RNA (mRNA)
IBA
08/2017 - 01/2011
2
Peptides (Polypeptides)
IBA
04/2015 - 12/2012
2
monophosphoryl lipid A
IBA
01/2014 - 08/2013
2
Mitoxantrone (Novantrone)
FDA Link
Generic
01/2014 - 03/2012
2
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2014 - 03/2012
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2014 - 03/2012
2
Interleukin-17 (Interleukin 17)
IBA
01/2011 - 03/2002
2
Protein Isoforms (Isoforms)
IBA
12/2008 - 12/2006
1
Trabectedin
IBA
01/2024
1
Mannose Receptor
IBA
01/2022
1
Apolipoproteins
IBA
01/2022
1
Apolipoproteins E (ApoE)
IBA
01/2022
1
HLA-DR Antigens (HLA-DR)
IBA
01/2022
1
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2022
1
Anaphylatoxins
IBA
01/2022
1
Lipase (Acid Lipase)
FDA Link
01/2022
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
12/2021
1
Complement C1s (C1 Esterase)
IBA
01/2021
1
Enzymes
IBA
01/2021
1
dehydroacetic acid (DHAS)
IBA
12/2019
1
atezolizumab
IBA
10/2019
1
Bevacizumab (Avastin)
FDA Link
10/2019
1
Complement C5a (Complement 5a)
IBA
01/2019
1
Androgens
IBA
01/2019
1
Immune Checkpoint Proteins
IBA
01/2019
1
Calreticulin
IBA
01/2016
1
Insulin (Novolin)
FDA Link
07/2015
Therapy/Procedure
34
Therapeutics
01/2024 - 11/2002
23
Immunotherapy
10/2023 - 04/2010
5
Precision Medicine
01/2020 - 08/2015
3
Drug Therapy (Chemotherapy)
01/2024 - 03/2011
2
Radiotherapy
01/2024 - 09/2013
2
Biological Therapy
05/2016 - 03/2012
2
Oncolytic Virotherapy
02/2016 - 06/2013
1
Immunomodulation
01/2023
1
Prostatectomy (Retropubic Prostatectomy)
01/2019
1
Nephrectomy
08/2017